Pfizer Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Recently, a new study funded by Pfizer was published in the Lancet Medical Journal, and it found that ...

The Pfizer COVID-19 vaccine remains 90% effective at reducing a person's risk of hospitalization from the virus six months after it is administered, a new study has found. This is true even in the face of the delta variant as well as if the person has not received a booster shot.

Un studiu publicat joi, 19 august, de cercetători de la Universitatea Oxford, a arătat că eficienţa împotriva Covid-19 a vaccinului dezvoltat de Pfizer şi BioNTech scade mai repede decât cea a serului AstraZeneca.

URL copied More data confirm single dose of Pfizer, AstraZeneca vaccines work Scientists at Oxford University have released more data that confirm coronavirus vaccines made by Pfizer-BioNTech and AstraZeneca both significantly cut the risk of infection after a single dose. In studies published on Friday, researchers said there was no apparent difference in the vaccines' ability to reduce COVID-19 infection rates. The research has not yet been published in a peer-reviewed journal but is based on data from nose and throat swabs taken from more than 370,000 participants in England and ...

If you've received your COVID-19 vaccine or scheduled an appointment to get it soon, be on the lookout for scammers seeking to target you afterward.